Pharmacist-led interventions to reduce unplanned admissions for older people: A systematic review and meta-analysis of randomised controlled trials

Age and Ageing

Volumn 43, Issue 2, 2014, Pages 174-187

  Thomas, Rebecca ^a   Huntley, Alyson L ^b   Mann, Mala ^a   Huws, Dyfed ^a   Elwyn, Glyn ^a   Paranjothy, Shantini ^a   Purdy, Sarah ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Medication review; Meta analysis; Older people; Pharmacist; Systematic review; Unplanned admissions

Indexed keywords

AUSTRALIA; CANADA; CLINICAL EFFECTIVENESS; COMMUNITY; COST EFFECTIVENESS ANALYSIS; DRUG USE; ELDERLY CARE; EUROPE; FOLLOW UP; HEART FAILURE; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MEDICATION THERAPY MANAGEMENT; META ANALYSIS; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT REFUSAL; UNITED KINGDOM; WESTERN HEMISPHERE;

MEDICATION REVIEW; META-ANALYSIS; OLDER PEOPLE; PHARMACIST; SYSTEMATIC REVIEW; UNPLANNED ADMISSIONS;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; COMMUNITY PHARMACY SERVICES; DRUG INTERACTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HEART FAILURE; HUMANS; MEDICATION ADHERENCE; MEDICATION ERRORS; MIDDLE AGED; ODDS RATIO; PATIENT ADMISSION; PATIENT SAFETY; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; POLYPHARMACY; PROFESSIONAL ROLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84896730252     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/aft169     Document Type: Review

References (33)

1. Department of Health. Primary care: agenda for action: February 1997, 1996, The Scottish Office, Department of Health Edinburgh; 126-7.
2. Department of Health. Choosing health through pharmacy: a programme for pharmaceutical public health 2005-2015, 2005, Department of Health London.
3. Lindley CM, Tully M, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in the elderly. Age Ageing, 1992; 21: 294-300.
4. Hohl CM, DankoffJ, Colacone A et al. Polypharmacy, adverse drug-related events, and potential interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38: 666-71.
5. Department of Health. Pharmacy in the future: implementing the NHS plan: a programme for pharmacy in the National Health Service, Department of Health. London, 2000.
6. Royal S, Smeaton L, Avery AJ et al. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 2006; 15: 23-31.
7. Holland RDJ, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2007; 65: 303-16.
8. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatients medical care. A systematic review. Arch Intern Med 2006; 166: 955-64.
9. OECD. 13/02/2012; Available at: http://www.oecd.org/document/58/0,3746,en_2649_201185_1889402_1_1_1_1,00.html.
10. Higgins JPT, Altman DG. Chapter 8: assessing risk of bias in included studies, in Cochrane handbook of systematic reviews of interventions. In: Higgins JPT, Green S, eds. Chichester: John Wiley and sons, 2008.
11. Lisby M, Thomsen A, Nielsen LP et al. The effect of systematic medication review in elderly patients admitted to an acute ward of internal medicine. Basic Clin Pharmacol Toxicol 2010; 106: 422-27.
12. McMullin ST, Hennenfent JA, Ritchie DJ et al. A prospective randomised trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 1999; 159: 2306-09.
13. Scullin C, McElnay JC. An innovative approach to integrated medicines management. J Eval Clin Pract 2007; 13: 781-8.
14. Spinewine A, Swine C, Dhillon S et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomised, controlled trial. Geriatr Soc 2007; 55: 658-65.
15. Gillespie U, Alassaad A, Henrohn D et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med 2009; 169: 894-900.
16. Lipton HL, Bird JA. The impact of clinical pharmacists consultations on geratric patients compliance and medical care use: a randomised controlled trial. Gerontologist 1994; 34: 307-15.
17. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberall H. A pharmacy discharge plan for hospitalised elderly patients: a randomised controlled trial. Age Ageing 2001; 30: 33-40.
18. Bond C, Matheson C, Williams S et al. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions. BJGP 2000; 50: 271-75.
19. Holland RDJ, Goodyer L, Hall S et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005; 330: 293-98.
20. Krska J, Cromarty JA, Arris F et al. Pharmacist-led medication review in patients over 65: a randomised, controlled trial in primary care. Age Ageing 2001; 30: 205-11.
21. Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care: the POLYMED randomised controlled trial. Age Ageing 2007; 36: 292-97.
22. Naunton M, Peterson GM. Evaluation of home-based followup of high-risk elderly patients discharged from hospital. J Pharm Prac Res 2003; 33: 176-82.
23. Sellors J, Kaczorowski J, Sellors C et al. A randomised controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Association 2003; 169: 17-22.
24. Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm 2003; 60: 1123-9.
25. Zermansky AG, Petty DR, Raynor DK et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323: 1-5.
26. Zermansky AG, Alldred DP, Petty DR et al. Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 2006; 35: 586-91.
27. Lopez CC, Falces SC, Cubi QD et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure. Farm Hospital 2006; 30: 328-42.
28. Stewart SS, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med 1998; 158: 1067-72.
29. Varma S, McElnay JC, Hughes CM et al. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 1999; 19: 860-69.
30. Bouvy ML, Heerdink ER, Urquhart J et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomised controlled study. J Cardiac Failure 2003; 9: 404-11.
31. Avery AJ, Rodgers S, Cantrill JA, Armstrong S et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 2012; 379: 1310-9.
32. Mårdby AC, Akerlind I, Jörgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns 2007; 69: 158-64 (Epub 29 Oct).
33. Haynes RB, Ackloo E, Sahota N et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008; CD000011. doi: 10.1002/14651858.CD000011.pub3